Heart Failure

When you're considering device therapy for a patient with heart failure, be sure to consult this concise reference for the latest information on who benefits most from which device.   In clear, straightforward prose, Dr. Feldman addresses: Resynchronization Therapy ICD Ultrafiltration Impulse Therapy Chronic Implantable Monitoring Bioimpedance EECP and more. With chapters devoted to monitoring the patient on device therapy and the future of device therapy in heart failure, this book makes an important contribution to patient care. Table of Contents . 1) Resynchronization Therapy. 2) ICD. 3) Ultrafiltration. 4) Impulse Therapy. 5) Chronic Implantable Monitoring. 6) Bioimpedance. 7) EECP. 8) The Tandem Heart (and similar devices). 9) The Role of Right Heart Catheterization in Management of Patients with Heart Failure. 10) The Use of Echocardiography in Evaluating the Heart Failure Patient and Response to Therapy. 11) Managing Cornary Disease in Patients with Heart Failure - the Role of PCI. 12) Minimally Invasive Treatment of Mitral Valve Disease. 13) Cardiac restriction with Acorn. 14) The future of device therapy in heart failure. 15) Patient monitoring and selection for devices - who do we treat when? Arthur M Feldman MD PhD After receiving his B.A. degree from Gettysburg College, and M.S. and Ph.D. degrees from the University of Maryland, Dr. Feldman served as a post-doctoral fellow in physiology at the Johns Hopkins University School of Medicine. After completing his medical degree at the Louisiana State University School of Medicine, he returned to Johns Hopkins where he served as an intern, resident and cardiology fellow. After joining the faculty in 1985, he was named the Director of the Belfer Laboratory for Molecular Biology of Heart Failure and the Director of the Heart Failure Research Program at The Johns Hopkins University School of Medicine. In 2004 Dr. Feldman joined the faculty at the University of Pittsburgh School of Medicine as the Harry S. Tack Professor of Medicine, Chief of the Division of Cardiology, and Director of the Cardiovascular Institute of the UPMC Health System. In 2002, Dr. Feldman was named the Magee Professor of Medicine and Chairman of the Department of Medicine at Jefferson Medical College. He is a past President of the Heart Failure Society of America and of the Association of Professors of Cardiology. He has served on the editorial boards of many scientific journals and was elected to membership in organizations including Alpha Omega Alpha, the Association of University Cardiologists, the American Society for Clinical Investigation and the Association of American Physicians. He has published over 200 peer-reviewed articles. Dr. Feldman's research has focused on molecular and clinical aspects of heart failure. Most recently he has chaired the Steering Committees for the PEECH, EMOTE and WEAR-IT trials and co-chaired the COMPANION study.